Costly eye drug and far cheaper alternative have similar side effects: study

LONDON (Reuters) - Injecting Roche's cancer drug Avastin as a cheap eye treatment does not appear to increase deaths or serious side effects, according to an independent study that is likely to fuel a row over the medicine's unapproved use.

via Reuters: Health News Read More Here..